F/M Emerald Life Sciences Innovation ETF (LFSC)
NASDAQ: LFSC · Real-Time Price · USD
29.92
-0.04 (-0.13%)
At close: Oct 7, 2025, 4:00 PM EDT
29.92
0.00 (0.00%)
After-hours: Oct 7, 2025, 4:15 PM EDT
LFSC Holdings Information
LFSC is an equity ETF with a total of 36 individual holdings. The top holdings are Travere Therapeutics stock at 6.87%, LivaNova at 5.78%, TransMedics Group at 5.18%, Cogent Biosciences at 4.70%, and Soleno Therapeutics at 4.68%.
Total Holdings
36
Top 10 Percentage
48.14%
Asset Class
Equity
ETF Category
Health
Assets
69.70M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | TVTX | Travere Therapeutics, Inc. | 6.87% |
| 2 | LIVN | LivaNova PLC | 5.78% |
| 3 | TMDX | TransMedics Group, Inc. | 5.18% |
| 4 | COGT | Cogent Biosciences, Inc. | 4.70% |
| 5 | SLNO | Soleno Therapeutics, Inc. | 4.68% |
| 6 | NKTR | Nektar Therapeutics | 4.65% |
| 7 | GH | Guardant Health, Inc. | 4.20% |
| 8 | RDNT | RadNet, Inc. | 4.18% |
| 9 | MDGL | Madrigal Pharmaceuticals, Inc. | 4.11% |
| 10 | BBIO | BridgeBio Pharma, Inc. | 3.80% |
| 11 | CORT | Corcept Therapeutics Incorporated | 3.67% |
| 12 | KRRO | Korro Bio, Inc. | 3.66% |
| 13 | UTHR | United Therapeutics Corporation | 3.51% |
| 14 | KALV | KalVista Pharmaceuticals, Inc. | 3.39% |
| 15 | WVE | Wave Life Sciences Ltd. | 3.23% |
| 16 | MIRM | Mirum Pharmaceuticals, Inc. | 3.09% |
| 17 | MMSI | Merit Medical Systems, Inc. | 2.93% |
| 18 | RARE | Ultragenyx Pharmaceutical Inc. | 2.76% |
| 19 | COLL | Collegium Pharmaceutical, Inc. | 2.68% |
| 20 | ATEC | Alphatec Holdings, Inc. | 2.52% |
| 21 | INSM | Insmed Incorporated | 2.45% |
| 22 | SVRA | Savara Inc. | 2.19% |
| 23 | AKRO | Akero Therapeutics, Inc. | 1.99% |
| 24 | AXSM | Axsome Therapeutics, Inc. | 1.94% |
| 25 | ITGR | Integer Holdings Corporation | 1.67% |
As of Oct 2, 2025